Patients treated with definitive concurrent chemotherapy and radiation therapy for stage III non-small cell lung cancer have longer overall survival when treated by highly experienced facilities, whether or not they are academic or community cancer centers.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/-e5v43fx8Fk/150311140929.htm
Concurrent chemoradiation treatment at high-volume facilities improves survival for NSCLC
11 marzo 2015
Volver